Picture of Minerva Neurosciences logo

NERV — Minerva Neurosciences News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeSmall CapSucker Stock

Minerva Neurosciences Inc reports results for the quarter ended in September - Earnings Summary

* Minerva Neurosciences Inc  NERV.OQ  reported a quarterly
adjusted loss of $1.29​​ per share for the quarter ended in
September. The mean expectation of four analysts for the quarter
was for a loss of $1.32 per share.
    * Reported revenue was zero​; analysts expected zero. 
    * Minerva Neurosciences Inc's reported EPS for the quarter
was a
loss of $1.29​.
    * The mean earnings estimate of analysts had risen by
about 17.4%
in the last three months.​ 
    * In the last 30 days one analyst negatively revised an
earnings
estimate 
    * Minerva Neurosciences Inc shares had fallen by 67.6% this
quarter and lost 53.3% so far this year.
    * The company reported a quarterly loss of $6.9 million.
    * Wall Street's median 12-month price target for Minerva
Neurosciences Inc is $8.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell." 

This summary was machine generated from Refinitiv data November
9 at 02:32 p.m.  ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2022      -1.32          -1.29          Beat
 Jun. 30 2022      -1.65          -1.63          Beat
 Mar. 31 2022      -1.48          -1.84          Missed
 Dec. 31 2021      -1.50          -4.00          Missed

Recent news on Minerva Neurosciences

See all news